A real-world study to assess the economic burden and clinical outcome in patients with relapsing-remitting multiple sclerosis treated with dimethyl fumarate in Greece

被引：0
|
作者：
Karachalios, G. [1 ]
Gourgioti, R. [1 ]
Alexopoulou, A. [1 ]
Kourlaba, G. [2 ]
机构：
[1] Genesis Pharma SA, Athens, Greece
[2] Natl & Kapodistrian Univ Athens, Med Sch, Dept Intens Care A, Athens, Greece
来源：
MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 2_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P278
引用
收藏
页码：309 / 310
页数：2
相关论文
共 50 条
  • [1] Real world experience with dimethyl fumarate in relapsing-remitting multiple sclerosis
    Cox, S. R.
    Jordan, S.
    Sharma, D.
    O'Boyle, G.
    Tubridy, N.
    Hutchinson, M.
    Mcguigan, C.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 614 - 615
  • [2] Safety and efficacy of dimethyl fumarate in a real-world relapsing-remitting multiple sclerosis population
    Barros, A.
    Sequeira, J.
    Sousa, A.
    Capela, C.
    Pedrosa, R.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 877 - 878
  • [3] Risk factors for lymphopenia in patients with relapsing-remitting multiple sclerosis treated with dimethyl fumarate
    Morales, Fabian Sierra
    Koralnik, Igor J.
    Gautam, Shiva
    Samaan, Soleil
    Sloane, Jacob A.
    JOURNAL OF NEUROLOGY, 2020, 267 (01) : 125 - 131
  • [4] Characterization of lymphopenia in relapsing-remitting multiple sclerosis patients treated with dimethyl fumarate and fingolimod
    Nakhaei-Nejad, M.
    Barilla, D.
    Lee, C-H.
    Blevins, G.
    Giuliani, F.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 618 - 618
  • [5] A Retrospective Analysis of Real-World Discontinuation Rates with Delayed-Release Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis
    Allan, Michelle
    Grant, Lindsay
    NEUROLOGY AND THERAPY, 2020, 9 (01) : 85 - 92
  • [6] Prospective Observational Study in a Cohort of Patients Affected by Relapsing-Remitting Multiple Sclerosis Treated with Dimethyl Fumarate
    Di Cristinzi, Maria
    Moiola, Lucia
    Pisa, Marco
    Sangalli, Francesca
    Dalla Costa, Gloria
    Radaelli, Marta
    Preziosa, Paolo
    Romeo, Marzia
    Boneschi, Filippo Martinelli
    Colombo, Bruno
    Esposito, Federica
    Martinelli, Vittorio
    Comi, Giancarlo
    NEUROLOGY, 2018, 90
  • [7] Actual adherence to dimethyl fumarate in patients with relapsing-remitting multiple sclerosis
    de Sa, Joao
    Ferreira, Joao
    Macedo, Ana M.
    REVISTA DE NEUROLOGIA, 2023, 76 : S1 - S6
  • [8] Prospective real world observational multi-center study in patients with relapsing-remitting multiple sclerosis treated with dimethyl fumarate in Campania, Italy
    Lanzillo, R.
    Sacca, F.
    Signoriello, E.
    Maniscalco, G. T.
    Bonavita, S.
    Lavorgna, L.
    Sinisi, L.
    Romano, F.
    De Angelis, M.
    Russo, C. V.
    Moccia, M.
    Carotenuto, A.
    De Rosa, A.
    Ronga, B.
    Florio, C.
    Lus, G.
    Morra, V. Brescia
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 920 - 921
  • [9] Immunophenotyping of Depression and Fatigue in Relapsing-Remitting Multiple Sclerosis (RRMS) Patients Treated with Dimethyl Fumarate
    Lee, Chieh-Hsin
    Zaeem, Zoya
    Barilla, David
    Nakhaei-Nejad, Maryam
    Giuliani, Fabrizio
    NEUROLOGY, 2019, 92 (15)
  • [10] Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview
    Bomprezzi, Roberto
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2015, 8 (01) : 20 - 30
12345